Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/biohaven-completes-enrollment-of-verdiperstat-arm-of-pivotal-healey-als-platform-trial-conducted-by-the-healey-center-for-als-at-massachussetts-general-hospital-301423211.html

PRNEWSWIRE
15 Nov 2021

https://www.reuters.com/business/healthcare-pharmaceuticals/biohavens-drug-candidate-neurological-disorder-fails-study-2021-09-27/

M. Maddipatla REUTERS
28 Sep 2021

https://www.biohavenpharma.com/investors/news-events/press-releases/08-03-2020

PRESS RELEASE
03 Aug 2020

https://www.prnewswire.com/news-releases/biohaven-completes-enrollment-ahead-of-timelines-in-international-phase-3-clinical-trial-of-verdiperstat-in-multiple-system-atrophy-301096602.html

PRNEWSWIRE
21 Jul 2020

https://www.prnewswire.com/news-releases/biohavens-verdiperstat-receives-fast-track-designation-for-the-treatment-of-multiple-system-atrophy-301025830.html

PRNEWSWIRE
18 Mar 2020

https://www.prnewswire.com/news-releases/biohaven-enrolls-first-patient-in-phase-3-clinical-trial-of-verdiperstat-oral-myeloperoxidase-inhibitor-for-the-treatment-of-multiple-system-atrophy-300893543.html

PR NEWSWIRE
31 Jul 2019